Trials / Completed
CompletedNCT04787965
Opicapone Treatment Initiation Open-Label Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 239 (actual)
- Sponsor
- Neurocrine Biosciences · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is an observational study to describe the treatment patterns and clinical outcomes observed with use of ONGENTYS as adjunctive treatment to levodopa/carbidopa in Parkinson's disease patients experiencing "off" episodes with motor fluctuations
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Opicapone | Opicapone as adjunctive treatment to levodopa/carbidopa over a 6-month period |
Timeline
- Start date
- 2021-03-01
- Primary completion
- 2022-08-04
- Completion
- 2022-08-04
- First posted
- 2021-03-09
- Last updated
- 2022-11-28
Locations
6 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04787965. Inclusion in this directory is not an endorsement.